Reduced atopic march risk in pediatric atopic dermatitis patients prescribed dupilumab versus conventional immunomodulatory therapy: A population-based cohort study

Overview of attention for article published in Journal of the American Academy of Dermatology, June 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 3 news outlets

twitter: 2 X users

Readers on

mendeley: 1 Mendeley

So far, Altmetric has seen 3 news stories from 3 outlets.

Pediatric Atopic Dermatitis: Study Suggests Treatment May Impact Atopic March

Pediatric News , 21 Jun 2024

TOPLINE: Pediatric patients with atopic dermatitis (AD) who are prescribed dupilumab may be at a reduced risk for atopic march…

Dupilumab zatrzymuje marsz alergiczny?

Termedia, 21 Jun 2024

Jak wynika z badań opublikowanych w „Journal of the American Academy of Dermatology”, podanie dupilumabu dzieciom z atopowym…

Can Dupilumab Halt Atopic March in Pediatric AD?

Medscape, 19 Jun 2024

TOPLINE: Pediatric patients with atopic dermatitis (AD) who are prescribed dupilumab may be at a reduced risk for atopic march…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.